SBCNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as SBCWW
SBC Medical Group Holdings Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$5.36+0.20 (+3.88%)
Close on Oct 19, 2026
- Market cap
- $549.81M
- P/E (TTM)
- 11.4
- Dividend yield
- –
Share price
+$1.17 (+27.77%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
SBC Medical Group Holdings Inc saw revenue fall 6.9% to $175.17M over the twelve months to Jun 30, 2026. Operating income rose 14.1% to $65.41M, moving the operating margin from 30.5% to 37.3%. Free cash flow was $61.77M.
Revenue
$175.17M
-6.9% vs. a year earlier
Operating income
$65.41M
+14.1% vs. a year earlier
Free cash flow
$61.77M
TTM Q2 2026
EPS, diluted
$0.47
+46.9% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $549.81M
- P/E ratio
- 11.4
- Price to sales
- 3.14
- Price to book
- 2.08
- Dividend yield
- –
- Free cash flow yield
- 11.23%
Fundamentals
- Revenue
- $175.17M
- Net income
- $49.03M
- EPS, diluted
- $0.47
- Free cash flow
- $61.77M
- Book value per share
- $2.57
- Diluted shares
- 103M
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
$175.17M-6.9% YoY
Gross profit
$125.86M-13.1% YoY
Operating income
$65.41M+14.1% YoY
Net income
$49.03M+47.1% YoY
EPS, diluted
$0.47+46.9% YoY
Free cash flow
$61.77M
Reported periodTrailing twelve months